| 1019O Clinical and translational data from the phase I SURPASS trial of ADP-A2M4CD8 T cell receptor (TCR) T cell therapy alone or combined with nivolumab in solid tumors VM Garcia, E Calvo, A Asch, M Butler, J Zugazagoitia, J Charlson, ... Annals of Oncology 34, S620-S621, 2023 | 2 | 2023 |
| 1025TiP SOLTI-1904: Efficacy of spartalizumab across multiple cancer-types in patients with PD1-high mRNA expressing tumors defined by a single and pre-specified cutoff (ACROPOLI) A Prat, L Paz-Ares, M Juan, E Felip, E Garralda, B González-Farré, ... Annals of Oncology 32, S859-S860, 2021 | | 2021 |
| 1056P Efficacy of spartalizumab across multiple cancer types in patients with PD1-high mRNA expressing tumors (SOLTI-1904 ACROPOLI) A Prat, T Pascual, M Juan, L Paz-Ares, E Felip, E Garralda, ... Annals of Oncology 34, S639-S640, 2023 | | 2023 |
| 1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study) M Nowacki, H Kroning, A Cervantes, F Husseini, J McKendrick, J Schuller, ... EJC Supplements 5 (1), S326, 2003 | 6 | 2003 |
| 1132 POSTER Epithelial-Mesenchymal Transition in Cancer of Unknown Primary A Stovianni, A Goussia, G Pentheroudakis, V Siozopoulou, A Cervantes, ... European Journal of Cancer, S133, 2011 | | 2011 |
| 116 Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: data from phase 1 and phase 2 studies J Strauss, F Braiteh, EC Aller, M De Miguel, A Cervantes, WJ Edenfield, ... International Journal of Gynecologic Cancer 31 (Suppl 3), 2021 | | 2021 |
| 1201P The role of a mini tumour mutational burden (TMB) score generated with a customized NGS panel to predict benefit from immunotherapy P Lombardi, V Gambardella, N Tarazona, JA Carbonell-Asins, ... Annals of Oncology 31, S789, 2020 | | 2020 |
| 138 Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer M Ibarrola-Villava, MJ Llorca-Cardeñosa, N Tarazona, C Mongort, ... European Journal of Cancer 3 (51), S11, 2015 | | 2015 |
| 1432P Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced gastric cancer patients M Cabeza-Segura, L Alarcón-Molero, V Gambardella, JA Carbonell-Asins, ... Annals of Oncology 32, S1070-S1071, 2021 | | 2021 |
| 1471P 3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients M Cabeza, F Papaccio, MFG Bravo, V Gambardella, C Alfaro-Cervello, ... Annals of Oncology 31, S919, 2020 | | 2020 |
| 1480P M2 macrophages could promote an immunosuppressive phenotype in a prospective cohort of advanced gastric cancer patients M Cabeza, V Gambardella, L Alarcón, G Herrera, Z Garzón-Lloría, ... Annals of Oncology 31, S922, 2020 | | 2020 |
| 1493P An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models V Gambardella, F Gimeno-Valiente, M Cabeza, F Papaccio, ... Annals of Oncology 31, S927, 2020 | | 2020 |
| 14LBA Randomized phase 3 study of panitumumab with FOLFIRI vs FOLFIRI alone as second-line treatment (tx) in patients (pts) with metastatic colorectal cancer (mCRC) M Peeters, T Price, Y Hotko, A Cervantes, M Ducreux, T André, E Chan, ... EJC Supplements 3 (7), 10, 2009 | 68 | 2009 |
| 152 EGF-induced acetylation of heterogeneous nuclear ribonucleoproteins is dependent on KRAS mutational status in colorectal cancer cells D Roda, J Castillo, M Telechea, A Gil, G Lopez, L Franco, ... European Journal of Cancer 3 (51), S15, 2015 | | 2015 |
| 1552P Clinical multi-omics analysis of gastric cancer (GC) in Europe (EU) and Latin America (LatAm): The LEGACy project TC Fleitas, F Ruiz-Pace, T van Schooten, R Barros, ... Annals of Oncology 34, S870, 2023 | | 2023 |
| 1565P Clinical outcome after perioperative treatment on locally advanced and borderline pancreatic cancer: Experience of a single academic center SR Keränen, C Pizzo, M Huerta, E Muñoz, C Alfaro-Cervello, R Aliaga, ... Annals of Oncology 31, S954, 2020 | | 2020 |
| 1590P Real-world gastric cancer (GC) in Latin America (LATAM) and Europe (EU) B Freile, S Derks, T van Schooten, F Carneiro, R Barros, C Caballero, ... Annals of Oncology 34, S885, 2023 | | 2023 |
| 1595P Connecting primary care with oncology through the implementation a cancer fast-track program: Reducing time from initial symptoms to diagnosis and initiation of treatment … MTM Martinez, B Ortega, S Simon, S Moragon, J Navarro, A Sanmartin, ... Annals of Oncology 31, S964, 2020 | 1 | 2020 |
| 1621P Efficacy and safety of erdafitinib in adults with pancreatic cancer and prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase II open-label … S Pant, D Arnold, J Tabernero, Y Loriot, G Folprecht, GM Haag, D Palmer, ... Annals of Oncology 34, S898, 2023 | 5 | 2023 |
| 1624P Impact of the COVID-19 pandemic in the cancer fast-track programme MTM Martinez, S Simón, J Montón-Bueno, S Moragón, BO Morillo, ... Annals of Oncology 32, S1154, 2021 | | 2021 |
Susana RosellóMedical Doctor in Hospital Clinico Universitario of Valencia, SpainVerified email at incliva.es